new warnings for patients taking Cylert (pemoline)

You'll see new warnings for patients taking Cylert (pemoline).

Cylert is no longer recommended for initial therapy of attention deficit disorder (ADD)...due to the risk of liver toxicity.

Now Abbott recommends that patients sign a consent form before starting Cylert...and get liver function tests EVERY TWO WEEKS.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote